Literature DB >> 25860033

Deleting the Redundant TSH Receptor C-Peptide Region Permits Generation of the Conformationally Intact Extracellular Domain by Insect Cells.

Chun-Rong Chen1, Larry M Salazar1, Sandra M McLachlan1, Basil Rapoport1.   

Abstract

The TSH receptor (TSHR) extracellular domain (ECD) comprises a N-terminal leucine-rich repeat domain and an hinge region (HR), the latter contributing to ligand binding and critical for receptor activation. The crystal structure of the leucine-rich repeat domain component has been solved, but previous attempts to generate conformationally intact complete ECD or the isolated HR component for structural analysis have failed. The TSHR HR contains a C-peptide segment that is removed during spontaneous TSHR intramolecular cleavage into disulfide linked A- and B-subunits. We hypothesized that deletion of the redundant C-peptide would overcome the obstacle to generating conformationally intact TSHR ECD protein. Indeed, lacking the C-peptide region, the TSHR ECD (termed ECD-D1) and the isolated HR (termed HR-D1) were secreted into medium of insect cells infected with baculoviruses coding for these modified proteins. The identities of TSHR ECD-D1 and HR-D1 were confirmed by ELISA and immunoblotting using TSHR-specific monoclonal antibodies. The TSHR-ECD-D1 in conditioned medium was folded correctly, as demonstrated by its ability to inhibit radiolabeled TSH binding to the TSH holoreceptor. The TSHR ECD-D1 purification was accomplished in a single step using a TSHR monoclonal antibody affinity column, whereas the HR-D1 required a multistep protocol with a low yield. In conclusion, we report a novel approach to generate the TSHR ECD, as well as the isolated HR in insect cells, the former in sufficient amounts for structural studies. However, such studies will require previous complexing of the ECD with a ligand such as TSH or a thyroid-stimulating antibody.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25860033      PMCID: PMC4475722          DOI: 10.1210/en.2015-1154

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  35 in total

1.  Evidence that the thyrotropin receptor ectodomain contains not one, but two, cleavage sites.

Authors:  G D Chazenbalk; K Tanaka; Y Nagayama; A Kakinuma; J C Jaume; S M McLachlan; B Rapoport
Journal:  Endocrinology       Date:  1997-07       Impact factor: 4.736

2.  Suppression of thyrotropin receptor constitutive activity by a monoclonal antibody with inverse agonist activity.

Authors:  Chun-Rong Chen; Sandra M McLachlan; Basil Rapoport
Journal:  Endocrinology       Date:  2007-02-01       Impact factor: 4.736

3.  Two-subunit structure of the human thyrotropin receptor.

Authors:  H Loosfelt; C Pichon; A Jolivet; M Misrahi; B Caillou; M Jamous; B Vannier; E Milgrom
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

4.  Research resource: Update and extension of a glycoprotein hormone receptors web application.

Authors:  Annika Kreuchwig; Gunnar Kleinau; Franziska Kreuchwig; Catherine L Worth; Gerd Krause
Journal:  Mol Endocrinol       Date:  2011-02-03

5.  Neutral antibodies to the TSH receptor are present in Graves' disease and regulate selective signaling cascades.

Authors:  Syed A Morshed; Takao Ando; Rauf Latif; Terry F Davies
Journal:  Endocrinology       Date:  2010-09-15       Impact factor: 4.736

6.  Relationship between thyrotropin receptor hinge region proteolytic posttranslational modification and receptor physiological function.

Authors:  Sepehr Hamidi; Chun-Rong Chen; Yumiko Mizutori-Sasai; Sandra M McLachlan; Basil Rapoport
Journal:  Mol Endocrinol       Date:  2010-11-24

7.  Defining structural and functional dimensions of the extracellular thyrotropin receptor region.

Authors:  Gunnar Kleinau; Sandra Mueller; Holger Jaeschke; Paul Grzesik; Susanne Neumann; Anne Diehl; Ralf Paschke; Gerd Krause
Journal:  J Biol Chem       Date:  2011-04-27       Impact factor: 5.157

8.  Crystal structure of the TSH receptor (TSHR) bound to a blocking-type TSHR autoantibody.

Authors:  Paul Sanders; Stuart Young; Jane Sanders; Katarzyna Kabelis; Stuart Baker; Andrew Sullivan; Michele Evans; Jill Clark; Jane Wilmot; Xiaoling Hu; Emma Roberts; Michael Powell; Ricardo Núñez Miguel; Jadwiga Furmaniak; Bernard Rees Smith
Journal:  J Mol Endocrinol       Date:  2011-02-15       Impact factor: 5.098

9.  Identification of key amino acid residues in a thyrotropin receptor monoclonal antibody epitope provides insight into its inverse agonist and antagonist properties.

Authors:  Chun-Rong Chen; Sandra M McLachlan; Basil Rapoport
Journal:  Endocrinology       Date:  2008-04-03       Impact factor: 4.736

10.  Crystal structure of the TSH receptor in complex with a thyroid-stimulating autoantibody.

Authors:  Jane Sanders; Dimitri Y Chirgadze; Paul Sanders; Stuart Baker; Andrew Sullivan; Anshu Bhardwaja; Jane Bolton; Magnus Reeve; Nobuhiro Nakatake; Michele Evans; Tonya Richards; Michael Powell; Ricardo Núñez Miguel; Tom L Blundell; Jadwiga Furmaniak; Bernard Rees Smith
Journal:  Thyroid       Date:  2007-05       Impact factor: 6.568

View more
  2 in total

1.  Hormone- and antibody-mediated activation of the thyrotropin receptor.

Authors:  Jia Duan; Peiyu Xu; Xiaodong Luan; Yujie Ji; Xinheng He; Ning Song; Qingning Yuan; Ye Jin; Xi Cheng; Hualiang Jiang; Jie Zheng; Shuyang Zhang; Yi Jiang; H Eric Xu
Journal:  Nature       Date:  2022-08-08       Impact factor: 69.504

2.  Autoantibody mimicry of hormone action at the thyrotropin receptor.

Authors:  Bryan Faust; Christian B Billesbølle; Carl-Mikael Suomivuori; Isha Singh; Kaihua Zhang; Nicholas Hoppe; Antonio F M Pinto; Jolene K Diedrich; Yagmur Muftuoglu; Mariusz W Szkudlinski; Alan Saghatelian; Ron O Dror; Yifan Cheng; Aashish Manglik
Journal:  Nature       Date:  2022-08-08       Impact factor: 69.504

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.